<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02385383</url>
  </required_header>
  <id_info>
    <org_study_id>RH-4074-OJ4</org_study_id>
    <nct_id>NCT02385383</nct_id>
  </id_info>
  <brief_title>An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational Study</brief_title>
  <official_title>An Intravenous Iron Based Protocol for Optimizing Haemoglobin in Anaemic Patients Prior to Fast-track Hip and Knee Arthroplasty - An Observational Follow up Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bisbebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gentofte Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vejle Sygehus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Regionshospitalet Viborg, Skive</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Farsø Sygehus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This observational study follows a cohort of patients scheduled for elective hip- or knee
      surgery but has preoperative anemia and are treated with Intravenous (IV) iron prior to
      surgery according to a recently introduced standardized treatment protocol at 6 high-volume
      surgical centres.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients presenting with preoperative anaemia prior to hip and knee arthroplasty has a high
      risk of receiving allogeneic blood transfusion and anaemia has been associated with increased
      postoperative morbidity and mortality. While IV-iron administration may raise Hb prior to
      surgery, existing guidelines for addressing and treating preoperative anaemia is not widely
      implemented for patients scheduled for elective total joint arthroplasty (TJA) in Denmark. In
      addition, causes of preoperative anaemia and the efficacy of preoperative IV-iron
      administration has not been sufficiently evaluated in elective TJA.

      This is a observational follow-up study among 6 Danish high volume surgical centres that has
      recently introduced a standardized anaemia screening and treatment protocol for patients with
      preoperative anaemia scheduled for total hip- or knee arthroplasty.

      Patients with iron deficiency anaemia or anaemia of chronic inflammation receive infusion of
      IV-iron (Monofer) 4 weeks prior to surgery as a part of the standard operating procedure on
      the department.

      The aim of this follow up study is to evaluate changes in Haemoglobin concentration,
      transfusion rate and postoperative morbidity in this cohort.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Transfusion Rate</measure>
    <time_frame>From date of admission to date of discharge (up to 30 days)</time_frame>
    <description>Blood transfusion (yes/no) during the entire hospital stay</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Classification of preoperative anemia</measure>
    <time_frame>4 weeks prior to surgery (baseline)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in hemoglobin concentration</measure>
    <time_frame>From date of preoperative blood sampling (baseline) to date of admission (Up to 4 weeks)</time_frame>
    <description>The change in Hb from the time of preoperative blood sampling to Hb sampled on the date of admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>No. of red blood cell units administered per patient</measure>
    <time_frame>From date of admission to date of discharge (up to 30 days)</time_frame>
    <description>No of blood units administered during the entire hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital stay</measure>
    <time_frame>From date of admission to Date of discharge (up to 30 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications and readmissions</measure>
    <time_frame>From date of surgery up to 90 days after surgery</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Anemia</condition>
  <condition>Arthroplasty, Replacement, Hip</condition>
  <condition>Arthroplasty, Replacement, Knee</condition>
  <arm_group>
    <arm_group_label>Patients with preoperative anemia following treatment protocol</arm_group_label>
    <description>Patients with preoperative anemia according to the WHO definition and treated with a protocol of Iitravenous iron prior to surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with preoperative anemia - Historical control</arm_group_label>
    <description>Cohort of preoperative anemic patients from the Lundbeckcentre Database. Serving as a historical control</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Iron-III Isomaltoside 1000</intervention_name>
    <description>Protocol for optimizing preoperative Hb using IV Iron-III Isomaltoside 1000</description>
    <arm_group_label>Patients with preoperative anemia following treatment protocol</arm_group_label>
    <other_name>Monofer</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard Care</intervention_name>
    <description>Standard Care in a historical control cohort</description>
    <arm_group_label>Patients with preoperative anemia - Historical control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for elective hip or knee arthroplasty presenting with preoperative
        anemia.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Scheduled for elective primary hip- or knee arthroplasty

          -  Preoperative hemoglobin &lt; 13 g/dl (males) or &lt; 12 g/dl (females)

          -  Included in the departments treatment protocol for preoperative anemia

        Exclusion Criteria:

          -  Cronic transfusion need

          -  Not able to give consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oeivind Jans, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Oeivind Jans, M.D., Ph.D.</last_name>
    <phone>+4521688012</phone>
    <email>oeivind.jans@rh.regionh.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bisbebjerg Hospital, Dept. of orthopedic surgery</name>
      <address>
        <city>Copenhagen NV</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jens Bagger, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Farsø Sygehus</name>
      <address>
        <city>Farsø</city>
        <zip>9640</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gentofte Hospital, Dept. of orthopedic surgery</name>
      <address>
        <city>Hellerup</city>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Søren Solgaard, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Søren Solgaard</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hvidovre Hospital, Department of orthopaedic surgery</name>
      <address>
        <city>Hvidovre</city>
        <zip>2650</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henrik Husted</last_name>
      <email>henrik.husted@hvh.regionh.dk</email>
    </contact>
    <investigator>
      <last_name>Henrik Husted</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vejle Sygehus, Dept. of orthopedic surgery</name>
      <address>
        <city>Vejle</city>
        <zip>7100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Per Kjærsgaard-Andersen, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Per Kjærsgaard-Andersen, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Viborg Sygehus, Dept. of orthopedic surgery</name>
      <address>
        <city>Viborg</city>
        <zip>8800</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2015</study_first_submitted>
  <study_first_submitted_qc>March 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2015</study_first_posted>
  <last_update_submitted>March 10, 2015</last_update_submitted>
  <last_update_submitted_qc>March 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Oeivind Jans</investigator_full_name>
    <investigator_title>M.D., Ph.D.</investigator_title>
  </responsible_party>
  <keyword>Patient Blood Management</keyword>
  <keyword>Preoperative anemia</keyword>
  <keyword>IV Iron</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

